Mauna Kea Technologies SA
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions… Read more
Mauna Kea Technologies SA (MKEAF) - Total Assets
Latest total assets as of December 2024: $16.25 Million USD
Based on the latest financial reports, Mauna Kea Technologies SA (MKEAF) holds total assets worth $16.25 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Mauna Kea Technologies SA - Total Assets Trend (2013–2024)
This chart illustrates how Mauna Kea Technologies SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Mauna Kea Technologies SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Mauna Kea Technologies SA's total assets of $16.25 Million consist of 55.6% current assets and 44.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.8% |
| Accounts Receivable | $1.47 Million | 9.1% |
| Inventory | $4.26 Million | 26.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.47 Million | 9.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Mauna Kea Technologies SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mauna Kea Technologies SA's current assets represent 55.6% of total assets in 2024, a decrease from 89.1% in 2013.
- Cash Position: Cash and equivalents constituted 11.8% of total assets in 2024, down from 70.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 4.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 26.2% of total assets.
Mauna Kea Technologies SA Competitors by Total Assets
Key competitors of Mauna Kea Technologies SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Mauna Kea Technologies SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Mauna Kea Technologies SA generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Mauna Kea Technologies SA is currently not profitable relative to its asset base.
Mauna Kea Technologies SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.27 | 0.54 | 2.35 |
| Quick Ratio | 0.14 | 0.43 | 2.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-24.33 Million | $ -12.41 Million | $ 10.21 Million |
Mauna Kea Technologies SA - Advanced Valuation Insights
This section examines the relationship between Mauna Kea Technologies SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 123.19 |
| Latest Market Cap to Assets Ratio | 1.08 |
| Asset Growth Rate (YoY) | -29.2% |
| Total Assets | $16.25 Million |
| Market Capitalization | $17.58 Million USD |
Valuation Analysis
Above Book Valuation: The market values Mauna Kea Technologies SA's assets above their book value (1.08 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Mauna Kea Technologies SA's assets decreased by 29.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Mauna Kea Technologies SA (2013–2024)
The table below shows the annual total assets of Mauna Kea Technologies SA from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $16.25 Million | -29.18% |
| 2023-12-31 | $22.94 Million | +15.89% |
| 2022-12-31 | $19.79 Million | -20.03% |
| 2021-12-31 | $24.75 Million | +20.10% |
| 2020-12-31 | $20.61 Million | -12.75% |
| 2019-12-31 | $23.62 Million | +19.53% |
| 2018-12-31 | $19.76 Million | -28.78% |
| 2017-12-31 | $27.75 Million | +38.92% |
| 2016-12-31 | $19.97 Million | -11.24% |
| 2015-12-31 | $22.50 Million | -5.04% |
| 2014-12-31 | $23.70 Million | -40.07% |
| 2013-12-31 | $39.54 Million | -- |